Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Non Operating Income (2019 - 2026)

Biodesix filings provide 8 years of Non Operating Income readings, the most recent being -$1.6 million for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 1724.49% to -$1.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$7.0 million, a 31.93% increase, with the full-year FY2025 number at -$7.4 million, up 12.34% from a year prior.
  • Non Operating Income hit -$1.6 million in Q1 2026 for Biodesix, up from -$2.0 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $98000.0 in Q1 2025 to a low of -$10.8 million in Q4 2023.
  • Median Non Operating Income over the past 5 years was -$2.0 million (2025), compared with a mean of -$3.0 million.
  • Biggest five-year swings in Non Operating Income: plummeted 83450.0% in 2024 and later surged 103.78% in 2025.
  • Biodesix's Non Operating Income stood at -$6.4 million in 2022, then crashed by 67.62% to -$10.8 million in 2023, then rose by 22.69% to -$8.4 million in 2024, then skyrocketed by 75.91% to -$2.0 million in 2025, then rose by 20.91% to -$1.6 million in 2026.
  • The last three reported values for Non Operating Income were -$1.6 million (Q1 2026), -$2.0 million (Q4 2025), and -$1.7 million (Q3 2025) per Business Quant data.